BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 15180904)

  • 1. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy.
    Adamus G; Yang S; Weleber RG
    Exp Eye Res; 2016 Jun; 147():161-168. PubMed ID: 27185162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated retinopathy in patients with breast carcinoma.
    Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
    Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
    Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological characterization of paraneoplastic retinopathy.
    Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
    Khan N; Huang JJ; Foster CS
    Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.
    Adamus G
    Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1680-8. PubMed ID: 25754855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H; Ogawa K; Nakagawa T
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA; Thirkill CE; Hart WM
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.
    Adamus G
    Autoimmun Rev; 2009 Mar; 8(5):410-4. PubMed ID: 19168157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.
    Adamus G; Amundson D; Seigel GM; Machnicki M
    J Autoimmun; 1998 Dec; 11(6):671-7. PubMed ID: 9878089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL; Thirkill CE
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract]   [Full Text] [Related]  

  • 18. Müller cell-specific autoantibodies in a patient with progressive loss of vision.
    Peek R; Verbraak F; Coevoet HM; Kijlstra A
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1976-9. PubMed ID: 9727423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy.
    Adamus G; Bonnah R; Brown L; David L
    BMC Ophthalmol; 2013 Sep; 13():48. PubMed ID: 24066722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies.
    Adamus G; Brown L; Weleber RG
    Exp Mol Pathol; 2009 Dec; 87(3):195-203. PubMed ID: 19744478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.